Nurix Therapeutics Inc’s filing revealed that its Chief Legal Officer Ring Christine unloaded Company’s shares for reported $82250.0 on Nov 04 ’24. In the deal valued at $25.00 per share,3,290 shares were sold. As a result of this transaction, Ring Christine now holds 28,084 shares worth roughly $0.62 million.
Then, CHRISTINE RING bought 3,290 shares, generating $80,506 in total proceeds.
Before that, Ring Christine sold 5,760 shares. Nurix Therapeutics Inc shares valued at $139,867 were divested by the Chief Legal Officer at a price of $24.28 per share. As a result of the transaction, Ring Christine now holds 28,084 shares, worth roughly $0.62 million.
UBS initiated its Nurix Therapeutics Inc [NRIX] rating to a Buy in a research note published on October 24, 2024; the price target was $35. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in mid October with a ‘”a Buy”‘ rating. Truist started covering the stock on July 31, 2024. It rated NRIX as “a Buy”.
Price Performance Review of NRIX
On Friday, Nurix Therapeutics Inc [NASDAQ:NRIX] saw its stock fall -1.43% to $22.05. Over the last five days, the stock has lost -3.80%. Nurix Therapeutics Inc shares have risen nearly 113.66% since the year began. Nevertheless, the stocks have risen 254.50% over the past one year. While a 52-week high of $29.56 was reached on 11/11/24, a 52-week low of $5.65 was recorded on 01/29/24. SMA at 50 days reached $24.37, while 200 days put it at $19.02.
Levels Of Support And Resistance For NRIX Stock
The 24-hour chart illustrates a support level at 21.66, which if violated will result in even more drops to 21.28. On the upside, there is a resistance level at 22.51. A further resistance level may holdings at 22.98. The Relative Strength Index (RSI) on the 14-day chart is 37.34, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.70, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 84.29%. Stochastics %K at 19.12% indicates the stock is a buying.
How much short interest is there in Nurix Therapeutics Inc?
A steep rise in short interest was recorded in Nurix Therapeutics Inc stocks on 2024-10-31, growing by 0.38 million shares to a total of 9.46 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 9.08 million shares. There was a rise of 4.02%, which implies that there is a positive sentiment for the stock.
